COMMUNIQUÉS West-GlobeNewswire

Oasmia Pharmaceutical AB (publ) Interim report for the period May – July 2018
31/08/2018
FIRST QUARTER May 1 – July 31, 2018 Consolidated net sales amounted to TSEK 128 compared to TSEK 20 in the first quarter the previous year Operating loss was TSEK 26,572 compared to TSEK 28,421 in the first quarter the [...]
Shire Completes Sale of Oncology Franchise
31/08/2018
Shire Completes Sale of Oncology Franchise Dublin, Ireland – August 31, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) announces today that it has completed the sale of its Oncology franchise to Servier S.A.S. for $2.4 [...]
GENFIT announces its upcoming participation in a number of investor and NASH-specific events over the next two months
31/08/2018
GENFIT announces its upcoming participation in a number of investor and NASH-specific events over the next two months Lille (France), Cambridge (Massachusetts, United States), August 31, 2018 - GENFIT (Euronext: GNFT - [...]
GENFIT : annonce sa participation à plusieurs événements financiers et dédiés à la NASH au cours des deux mois à venir
31/08/2018
GENFIT : annonce sa participation à plusieurs événements financiers et dédiés à la NASH au cours des deux mois à venir Lille (France), Cambridge (Massachusetts, États-Unis), le 31 août 2018 - GENFIT (Euronext : GNFT - [...]
Fagron NV: Disclosure of received notification
31/08/2018
Regulated information Nazareth (Belgium)/Rotterdam (the Netherlands), 31 August 2018 Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron received the [...]
Herantis Pharma Plc's Board decision on new stock option program for key employees
31/08/2018
Herantis Pharma Plc's Board decision on new stock option program for key employees Herantis Pharma Plc Company release 31 Aug 2018 at 9:00 AM The Board of Directors of Herantis Pharma Plc ("Herantis") has decided on a [...]
Shire plc: Rule 2.9 Announcement
31/08/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 31 August 2018 [...]
DBV Technologies to Attend Upcoming Investor Conferences
31/08/2018
Montrouge, France, August 31, 2018 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, [...]
DBV Technologies invitée à présenter lors des prochaines Conférences Investisseurs
31/08/2018
Montrouge, France, le 31 aout (7H30 CEST), 2018 DBV Technologies invitée à présenter lors des prochaines Conférences Investisseurs DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq : DBVT), société [...]
Correction: On “Grindeks” Results in the First Six Months of 2018
31/08/2018
Notice: missed attachment of the company's financial statements of Q2 added. Turnover of “Grindeks” reaches 71.5 million euro in the first six months of 2018; profit – 6.7 million euro Today, on 30 August, the JSC “ [...]
Esperite N.V. (ESP) : Update to the market on the publication of the Annual Report 2017.
31/08/2018
Amsterdam, The Netherlands - 31 August 2018 Esperite NV announced mid-August that the Company had solved the technical issues that caused the delay regarding the publication of the Annual Report 2017. The departments [...]
Kiadis Pharma announces Financial Results for the six months ended June 30, 2018 and Company update
31/08/2018
Kiadis Pharma announces Financial Results for the six months ended June 30, 2018 and Company update Amsterdam, The Netherlands, August 31, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam [...]
Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 August 2018
31/08/2018
Company Release no. 16/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 31 August 2018 Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 August 2018 Veloxis Pharmaceuticals A/S [...]
Reata Announces Receipt of $30 Million Milestone Payment From Kyowa Hakko Kirin
31/08/2018
IRVING, Texas, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA), a clinical-stage biopharmaceutical company, today announced that it has received a $30 million milestone payment from its [...]
MacroGenics Announces Participation in Three Upcoming Investor Conferences
31/08/2018
Rockville, MD, Aug. 30, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Merus participera à la 13ème Conférence annuelle sur les biotechnologies de Citi
30/08/2018
UTRECHT, Pays-Bas, 30 août 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), une société d'immuno-oncologie au stade clinique qui développe des traitements innovants à base d'anticorps bispécifiques (Biclonics®), a [...]
Dentsply Sirona to Present at the Baird 2018 Global Healthcare Conference on September 5th
30/08/2018
YORK, Pa., Aug. 30, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq:XRAY), The Dental Solutions Company, today announced it will participate in the Baird 2018 Global Healthcare Conference on [...]
Trevena to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
30/08/2018
CHESTERBROOK, Pa., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today, announced it will be featured as a presenting company at the 20th Annual Rodman & Renshaw Global Investment Conference, [...]
Marinus Pharmaceuticals to Present at the Baird Healthcare Conference
30/08/2018
RADNOR, Pa., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and [...]

Pages